Skip to main content

Table 1 Plasma levels of novel biomarkers for dysplipidemia and dysbiosis during the follicular, ovulatory and luteal phase of 30 menstrual cycles in 17 regularly menstruating women

From: Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers

Parameter Follicular phase
Mean ± SD
Median
Ovulatory phase
Mean ± SD
Median
Luteal phase
Mean ± SD
Median
TMAO (ng/µL) 0.35 (± 0.33)
0.25
0.31 (± 0.24)
0.21
0.25 (± 0.14)
0.22
Betaine (ng/µL) 3.99 (± 10.7)
4.11
4.20 (± 1.01)
4.13
3.81 (± 1.12)
3.67
Choline (ng/µL) 4.98 (± 0.85)
4.79
5.15 (± 0.87)
4.98
4.93 (± 1.00)
4.96
Non-HDL-C (mmol/L) 2.7 (± 0.72)
2.45
2.51 (± 0.64)
2.45
2.60 (± 0.71)
2.60
Remnant-C (mmol/L) 0.33 (± 0.12)
0.30
0.30 (± 0.15)
0.30
0.38 (± 0.17)
0.40
ApoB (g/L) 0.80 (± 0.17)
0.75
0.73 (± 0.16)
0.70
0.74 (± 0.18)
0.68
Non-HDL-C/HDL 1.56 (± 0.63)
1.36
1.40 (± 0.67)
1.24
1.40 (± 0.59)
1.27
ApoB/HDL 0.46 (± 0.17)
0.40
0.41 (± 0.18)
0.38
0.40 (± 0.15)
0.36
Remnant-C/HDL 0.19 (± 0.12)
0.17
0.17 (± 0.12)
0.15
0.21 (± 0.12)
0.19
  1. TMAO, trimethylamine N-oxide; non-HDL-C, non-High-Density Lipoprotein-Cholesterol; remnant-C, remnant-Cholesterol; ApoB, Apolipoprotein B